BioVie Inc.
NASDAQ:BIVI
1.59 (USD) • At close September 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 229,377 | 0.229 | 0.267 | 0.237 | 0.229 | 0.229 | 0.229 | 0.229 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -229,377 | -0.229 | -0.267 | -0.237 | -0.229 | -0.229 | -0.229 | -0.229 | -0.229 | -0.051 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9,266,734 | 23.1 | 33.3 | 17.258 | 133.188 | 1.151 | 1.008 | 0.371 | 0.466 | 0.038 | 0.004 | 0.049 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 1.259 | 1.772 | 0.858 | 0.343 | 0.229 | 0.273 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8,570,089 | 8.85 | 11.552 | 9.765 | 4.637 | 1.313 | 1.259 | 1.772 | 0.858 | 0.343 | 0.229 | 0.273 | 0.07 |
| Other Expenses
| 0 | 0 | 0.228 | 0.23 | 0.229 | 0.229 | 0.229 | 0 | 0.229 | 0.051 | 0 | 0 | 0 |
| Operating Expenses
| 17,836,823 | 31.95 | 45.08 | 27.253 | 138.054 | 2.693 | 2.497 | 2.143 | 1.554 | 0.432 | 0.233 | 0.322 | 0.07 |
| Operating Income
| -18,066,200 | -32.18 | -45.08 | -27.253 | -138.054 | -2.693 | -2.497 | -2.372 | -1.554 | -0.432 | -0.233 | -0.322 | -0.07 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 154,615 | 0.059 | -5.175 | 1.169 | 7.805 | -13.984 | 0.052 | -0.041 | 0.223 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -17,911,585 | -32.121 | -50.256 | -26.084 | -130.249 | -16.677 | -2.444 | -2.413 | -1.331 | -0.432 | -0.233 | -0.322 | -0.07 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 |
| Net Income
| -17,911,585 | -32.121 | -50.256 | -26.084 | -130.249 | -16.677 | -2.444 | -2.413 | -1.331 | -0.432 | -0.233 | -0.322 | -0.07 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -12.12 | -73 | -154.7 | -105.8 | -1,482.3 | -685.2 | -98.2 | -317.7 | -186.1 | -61.9 | -33.4 | -46.2 | -0.212 |
| EPS Diluted
| -12.12 | -73 | -154.7 | -106 | -1,482.3 | -685.2 | -98.2 | -317.7 | -186.1 | -61.9 | -33.4 | -46.2 | -0.212 |
| EBITDA
| -18,066,200 | -31.95 | -44.851 | -26.98 | -129.46 | -2.464 | -2.266 | -2.143 | -1.324 | -0.381 | -0.233 | -0.322 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |